 |
|
|
| |
Boceprevir Plus Peginterferon/Ribavirin for the Treatment of HCV/HIV Co-Infected Patients
|
| |
| |
Reported by Jules Levin IDSA Boston, MA Oct 22 2011
M Sulkowski1, S Pol2, C Cooper3, H Fainboim4, J Slim5, A Rivero6, S Thompson7, W Greaves7, J Wahl7, J Mallolas8
1John Hopkins University School of Medicine, Baltimore, MD; 2Hopital Cochin, Paris, France; 3The Ottawa Hospital, Ottawa, ON, Canada; 4F. J. Muñiz Hospital De Infecciosas, Buenos Aires, Argentina; 5Saint Michael's Medical Center, Newark, NJ; 6Hospital Universitario Reina Sofia, Córdoba, Spain; 7Merck Sharp & Dohme, Whitehouse Station, NJ; 8Hospital Clinic i Provincial Barcelona, Spain
Late Breaker Oral Abstract LB-37
Infectious Diseases Society of America (IDSA) 49th Annual Meeting
Boston MA
October 22nd, 2011
|
| |
|
|
|
|
|
